Basit öğe kaydını göster

Arthritis during interferon beta-1b treatment in multiple sclerosis

dc.contributor.authorAltintas, A
dc.contributor.authorAlici, Y
dc.contributor.authorMelikoglu, M
dc.contributor.authorSiva, A
dc.date.accessioned2021-03-05T11:44:39Z
dc.date.available2021-03-05T11:44:39Z
dc.date.issued2002
dc.identifier.citationAltintas A., Alici Y., Melikoglu M., Siva A., "Arthritis during interferon beta-1b treatment in multiple sclerosis", MULTIPLE SCLEROSIS, cilt.8, ss.534-536, 2002
dc.identifier.issn1352-4585
dc.identifier.othervv_1032021
dc.identifier.otherav_a9b31ae7-fb98-4e14-827e-95ee159932f7
dc.identifier.urihttp://hdl.handle.net/20.500.12627/113346
dc.identifier.urihttps://doi.org/10.1191/1352458502ms852xx
dc.description.abstractInterferon beta (IFN-beta) is the most widely prescribed disease-modifying drug for multiple sclerosis (MS). Therapy with IFN-beta may be associated with a number of adverse reactions. The development or exacerbation of other autoimmune diseases is a rare but reported side effect of IFN-beta therapy. In this case report, we present clinical and laboratory findings of two MS patients who developed arthritis during IFN-beta1b treatment probably of autoimmune origin.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.subjectNöroloji
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.titleArthritis during interferon beta-1b treatment in multiple sclerosis
dc.typeMakale
dc.relation.journalMULTIPLE SCLEROSIS
dc.contributor.department, ,
dc.identifier.volume8
dc.identifier.issue6
dc.identifier.startpage534
dc.identifier.endpage536
dc.contributor.firstauthorID166685


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster